Does Everyone Need High Technology Intervention Before They Die?

Smedira, Nicholas G; Whyte, Richard I; Sade, Robert M

Smedira, Nicholas G; Whyte, Richard I; Sade, Robert M.

Afiliación

Smedira NG; Department of Thoracic and Cardiovascular Surgery, Cleveland Clinic Foundation, Heart and Vascular Institute, Cleveland, Ohio.
Whyte RI; Department of Surgery (General Thoracic Surgery), Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Sade RM; Division of Cardiothoracic Surgery, Department of Surgery, Medical University of South Carolina, Charleston, South Carolina. Electronic address: sader@musc.edu.

Semin Thorac Cardiovasc Surg ; 2022 Oct 26.

Article en En | MEDLINE | ID: mdl-36307005

RESUMEN

A persistent problem in cardiothoracic surgery, as in all of medicine, is when to offer or to withhold expensive technologies. The ethical requirement of balancing harms and benefits is often difficult to achieve. The use of LVADs is an example of such technologies, and when to offer it is explored in this paper.

Palabras clave

Ethics; end-of-life care; health policy; ventricular assist device

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Semin Thorac Cardiovasc Surg Asunto de la revista: ANGIOLOGIA / CARDIOLOGIA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google